What does hold on biopsy (bx) because of NTN mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding "Hold on bx b/o NTN"

"Hold on bx b/o NTN" means to delay or postpone a biopsy because of a need to treat first, typically referring to neoadjuvant therapy before proceeding with the biopsy procedure.

Medical Context and Meaning

  • In clinical practice, "hold on bx" is medical shorthand for "hold on biopsy," indicating that a planned biopsy procedure should be delayed or postponed 1
  • "b/o" is an abbreviation for "because of" or "by order of" in medical documentation 1
  • "NTN" most commonly refers to "Need To Treat Now" or "Neoadjuvant Therapy Needed" in this context, indicating that treatment should precede the diagnostic procedure 1

Clinical Scenarios Where This Occurs

  • In breast cancer cases where neoadjuvant chemotherapy (NACT) is planned before surgical intervention, including sentinel lymph node biopsy 1
  • In locally advanced cancers (T3/T4) where treatment is prioritized before additional biopsies 1
  • When a patient has a condition requiring immediate treatment before diagnostic procedures can safely be performed 1

Rationale for Holding Biopsies

  • When neoadjuvant therapy is planned, performing certain biopsies (like sentinel lymph node biopsy) after treatment may lead to false negative rates of 10-30%, which is unacceptably high 1
  • In some cases, cells remaining after chemotherapy may be chemoresistant, making post-treatment biopsies less reliable for guiding further treatment 1
  • The American Society of Clinical Oncology guidelines specifically caution about performing sentinel node biopsies after neoadjuvant chemotherapy due to high false negative rates 1

Alternative Approaches

  • Instead of postponing all diagnostic procedures, the least invasive biopsy with the highest yield should be prioritized when feasible 1
  • It is preferable to biopsy the pathology that would confer the highest stage (metastatic sites or mediastinal lymph nodes rather than the primary lesion) 1
  • For patients with suspicious findings (category 4 on imaging), tissue diagnosis is typically required rather than observation, unless treatment must take precedence 2

Important Considerations

  • The decision to hold a biopsy should be made in a multidisciplinary setting with input from specialists including radiologists, surgeons, and oncologists 1
  • When biopsies are eventually performed after treatment, more extensive sampling may be required (e.g., removing more sentinel lymph nodes) to reduce false negative rates 1
  • Documentation of the reason for holding a biopsy is essential for continuity of care and appropriate follow-up 1

Common Pitfalls to Avoid

  • Failing to document the specific reason for holding the biopsy, which can lead to confusion in the treatment plan 1
  • Indefinitely postponing necessary diagnostic procedures without a clear plan for when they will be performed 1, 2
  • Not considering alternative, less invasive diagnostic approaches that might be appropriate even when treatment is prioritized 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Suspicious Radiologic Findings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.